Features

When prescribed by a healthcare professional S. 79 is generally well tolerated at the recommended dose and may be prescribed for infants, children, pregnant and lactating women, and the elderly.
The easy-to-swallow tablet can be halved or crushed to facilitate low-dose prescribing for infants and children.
Background Information

Connective tissue: Silica acts as an important connective tissue cross-linking agent, contributing to the architecture and resilience of connective tissue by building bridges between elastin, collagen and mucopolysaccharides (such as chondroitin sulfate and other glycosaminoglycans), which aids in tissue stability and rigidity.
Bone, cartilage and teeth: In the early stages of bone development, silica is intimately involved in the incorporation of calcium and phosphate into bone apatite, helping to increase the rate of mineralisation of new bone. It acts as a nucleating agent or seed crystal around which bone mineralisation progresses, and thus is necessary for the initiation of bone growth (for example during foetal development and bone repair). Silica is also involved in the growth of cartilage and teeth.
Ingredients

Silicon dioxide 33 mg

(elemental silica 15.4mg)

(contains 300mg of lactose per tablet)

Directions

Adults – Take 1 tablet 3 times a day with meals, or as professionally prescribed.

Children under 12 years – As professionally prescribed.

Blackmores Silica

€15.00Price